GMO Benchmark-Free Allocation Fund Class I GBMIX Fund Analysis

| Medalist Rating as of | See GMO Investment Hub

Morningstar’s Analysis GBMIX

Will GBMIX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

A consistent, if unconstrained, execution of valuation-driven investing.

Analyst Vedran Beogradlija

Vedran Beogradlija

Analyst

Summary

GMO Benchmark-Free Allocation stands apart from peers as a pure expression of the firm’s valuation-focused investment philosophy. An expert duo backed by robust resources shepherds the strategy, but the unconstrained approach can face unique challenges.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Sponsor Center